(Q43818757)

27 November 2017

title

The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure (English)

1 reference

27 November 2017

1 reference

A Yildirir

1 reference

27 November 2017

E Sade

series ordinal

1 reference

27 November 2017

L Tokgozoglu

series ordinal

1 reference

27 November 2017

A Oto

series ordinal

1 reference

27 November 2017

publication date

1 December 2001

1 reference

European Journal of Heart Failure

27 November 2017

published in

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

page(s)

717-721

1 reference

Should asymptomatic ventricular arrhythmias in patients with congestive heart failure be treated with antiarrhythmic drugs?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Can drug effects on mortality in heart failure be predicted by any surrogate measure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Cellular electrophysiological changes during ischemia in isolated, coronary-perfused cat ventricle with healed myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

QT dispersion and sudden unexpected death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Congestive heart failure and arrhythmias: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Nonuniform recovery of excitability in the left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Prognostic value of arrhythmogenic markers in systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

10.1016/S1388-9842(01)00191-X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference